An observational study in Chronic Kidney Disease, sponsored by Assiut University. Not yet recruiting. Open to participants aged 6 Months to 12 Years. Per ClinicalTrials.gov, last updated 2026-08-31.
Sponsored by Assiut University · Observational
Among 35 studies in Renal Insufficiency, Chronic by Assiut University — 25 open to participants now, 25 under way, 1 of them phase 3. Renal Insufficiency, Chronic · Assiut University.
Among the 35 studies in Renal Insufficiency, Chronic by Assiut University, this one is the 10th largest by planned enrollment of the 29 observational ones that give a count, is one of 12 that started in 2026, is one of 29 observational ones, reaches primary completion later than 15 of the 24 other live ones, and was the 29th registered.
3,090 studies on the registry are indexed under Renal Insufficiency, Chronic; 698 are open to participants now.
Browse Renal Insufficiency, Chronic studies →25 of the 35 studies in Renal Insufficiency, Chronic by Assiut University are open now, in 1 country. Recruiting first, the newest first:
Assiut University · Sites in Egypt
Assiut University
Assiut University · Sites in Egypt
Assiut University
Assiut University
By country, each count listing its studies:
Of the 435 Renal Insufficiency, Chronic studies recruiting now, 245 (56%) set no upper age limit and 111 (26%) stop at 75 or younger; 45 take children under 18; 80 take healthy volunteers.
This study: 6 Months to 12 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
35 studies; the count open now beside each. This study's row is marked.
First in 2018; this study’s year is marked. 12 started in 2026.
This study's planned enrollment of 128 is below the median of 213 across 834 observational studies indexed under Renal Insufficiency, Chronic.
Median enrollment 99 across the 6 interventional studies, 100 across the 29 observational. None of them has completed or been terminated yet.
This tab as a report to print or save as PDF → With an account.
Assiut University is the lead sponsor of 5,078 studies on the registry; 2,178 are open to participants now.
Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
12 of the studies in Renal Insufficiency, Chronic by Assiut University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07394920Assiut UniversityThe Role of Sodium Bicarbonate Enema in Improving Constipation and Reducing Uremic Toxins in Chronic Kidney Disease Patients. | 2027-03 |
| NCT06392425Assiut UniversityRole of Serum ADAM 17 (A Disintegrin And Metalloprotease 17) and Caspase 3 in Patients With Chronic Kidney Disease | 2027-03-31 |
| NCT07547852Assiut UniversityPleural Effusion Types in Chronic Kidney Disease | 2027-05 |
| NCT07805109Assiut UniversitySubclinical Renal Dysfunction in Rheumatoid Arthritis | 2027-09-01 |
| NCT07803237Assiut UniversityPredictors of Rapid CKD Progression | 2027-09-01 |
Among the 35 studies in Renal Insufficiency, Chronic by Assiut University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
To assess the effect of various nutritional interventions including the use of specific milk formulas on healthy status, growth parameters, body composition, skeletal muscle mass and functional capacity in patients with chronic kidney disease.
The Kidney Disease Improving Global Outcomes (KDIGO) 2024 defined the chronic kidney disease as abnormalities of kidney structure or function, present for a minimum of 3 months, with implications for health. CKD is classified based on Cause, Glomerular filtration rate (GFR) category (G1-G5), and Albuminuria category (A1-A3).
Nutritional management of pediatric patients with kidney disease is challenging as they undergo continued growth and development. So providing adequate nutrition for growth while minimizing disease progression and complications is the primary challenge.
There are many reasons for poor growth in children with (CKD), One of the most important of these is inadequate nutritional intake which may be due to anorexia, which is common in CKD, gastro-esophageal reflux with recurrent vomiting. The consequences of poor nutrition in children are suboptimal growth and impaired achievement of final height potential, abnormal body composition, developmental delay, a worsening of uremic symptoms such as vomiting, protein-energy wasting, and increased mortality.
optimizing the dietary prescription for the child with CKD is of vital importance at any age to promote growth and reverse growth failure if present.
During progression of chronic kidney disease, the requirements and utilization of different nutrients change significantly. These changes ultimately place patients with kidney disease at higher risk for nutritional and metabolic abnormalities so regular assessment of nutritional status and provision of suitable nutrition are key parts in the overall management of children with CKD aiming at preventing protein-energy malnutrition, meeting the patient's micronutrients needs and preventing overnutrition and the long-term implications of an undesirable eating routine.
unbalanced dietary pattern, characterized by high animal protein content: may worsen metabolic control, accelerate renal deterioration and consequently aggravate the stage of the chronic kidney disease in pediatric patients.
CKD is associated with chronic low-grade inflammation causing catabolic destruction of structural and functional proteins, resulting in skeletal muscle wasting, leading to progressive weight loss, muscle weakness in children resulting in a decrease in functional capacity.
Patients with advanced CKD are at high risk of cardiovascular disease (CVD). Complex changes in both the cardiac and vascular systems results in structural and functional changes that can lead to reduced exercise tolerance, quality of life and ultimately premature death.
A multidisciplinary team should consistently communicate the same messages about nutrition to provide support to the family. Educational resources, whether verbal, written, pictorial, or digital, must be adapted to suit the learning style of the child and family so that they understand the need for any nutritional interventions. This understanding, in turn, will lead to better adherence and improved outcomes for the child with CKD.
School age children with CKD from 6_12 years with all stages of CKD according to KDIGO classification
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Targeted nutritional management for children with chronic kidney disease and its impact on their health status and functional capacity
optimizing the dietary prescription for the children with CKD to promote growth and reverse growth failure if present aiming at preventing protein-energy malnutrition, meeting the patient's micronutrients needs and preventing overnutrition and the long-term implications of an undesirable eating routine.
Time frame: One year
No study locations are listed for this record.
Start is estimated for Oct 2026; primary completion for Sep 2027, 11 months later.
Of 274 non-industry observational studies under Renal Insufficiency, Chronic, half reached primary completion within 59 months of starting (the median), counting those still running; a quarter within 24 and three quarters within 192. This study's planned 11 months is below that.
Counting every sponsor, half of 325 studies reached it within 45 months; a quarter within 22 and three quarters within 191.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Renal Insufficiency, Chronic →